Annual Cash & Cash Equivalents
$143.94 M
+$56.06 M+63.79%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual cash & cash equivalents is $143.94 million, with the most recent change of +$56.06 million (+63.79%) on December 31, 2023.
- During the last 3 years, TSHA annual cash & cash equivalents has fallen by -$107.31 million (-42.71%).
- TSHA annual cash & cash equivalents is now -42.71% below its all-time high of $251.25 million, reached on December 31, 2020.
Performance
TSHA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$157.69 M
-$15.05 M-8.72%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly cash and cash equivalents is $157.69 million, with the most recent change of -$15.05 million (-8.72%) on September 30, 2024.
- Over the past year, TSHA quarterly cash and cash equivalents has dropped by -$6.59 million (-4.01%).
- TSHA quarterly cash and cash equivalents is now -43.41% below its all-time high of $278.63 million, reached on September 30, 2020.
Performance
TSHA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TSHA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.8% | -4.0% |
| 3 y3 years | -42.7% | -16.5% |
| 5 y5 years | +100.0% | - |
TSHA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +63.8% | -8.7% | +359.6% |
| 5 y | 5-year | -42.7% | -100.0% | -43.4% | +1307.9% |
| alltime | all time | -42.7% | -100.0% | -43.4% | +1307.9% |
Taysha Gene Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $157.69 M(-8.7%) |
| Jun 2024 | - | $172.74 M(+39.3%) |
| Mar 2024 | - | $123.98 M(-13.9%) |
| Dec 2023 | $143.94 M(+63.8%) | $143.94 M(-12.4%) |
| Sep 2023 | - | $164.28 M(+264.4%) |
| Jun 2023 | - | $45.08 M(-28.9%) |
| Mar 2023 | - | $63.42 M(-27.8%) |
| Dec 2022 | $87.88 M | $87.88 M(+156.2%) |
| Sep 2022 | - | $34.31 M(-48.2%) |
| Jun 2022 | - | $66.24 M(-31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $96.63 M(-35.2%) |
| Dec 2021 | $149.10 M(-40.7%) | $149.10 M(-21.0%) |
| Sep 2021 | - | $188.78 M(-4.3%) |
| Jun 2021 | - | $197.37 M(-13.7%) |
| Mar 2021 | - | $228.68 M(-9.0%) |
| Dec 2020 | $251.25 M(>+9900.0%) | - |
| Dec 2020 | - | $251.25 M(-9.8%) |
| Sep 2020 | - | $278.63 M(+2387.8%) |
| Jun 2020 | - | $11.20 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual cash & cash equivalents year-on-year change?
- What is Taysha Gene Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly cash and cash equivalents year-on-year change?
What is Taysha Gene Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of TSHA is $143.94 M
What is the all time high annual cash & cash equivalents for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual cash & cash equivalents is $251.25 M
What is Taysha Gene Therapies annual cash & cash equivalents year-on-year change?
Over the past year, TSHA annual cash & cash equivalents has changed by +$56.06 M (+63.79%)
What is Taysha Gene Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TSHA is $157.69 M
What is the all time high quarterly cash and cash equivalents for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly cash and cash equivalents is $278.63 M
What is Taysha Gene Therapies quarterly cash and cash equivalents year-on-year change?
Over the past year, TSHA quarterly cash and cash equivalents has changed by -$6.59 M (-4.01%)